Clinical outcome tracking and analysis

Abstract

The described invention provides a system and method for clinical outcome tracking and analysis. The clinical outcome tracking and analysis comprises sorting, outcome tracking, quality of life metrics, toxicity to therapy and cost of care. The system and method includes receiving one or more parameters. Exemplary parameters for sorting include sex, age, ethnicity, comorbidities, tobacco use, source of insurance, medical record number, primary care physician, referring physician, hospital, approved service vendors, disease-specific clinical molecular phenotype, therapy intent, stage of therapy, biomarkers, and cost of care. A plurality of patient medical records are sorted, by a clinical outcome tracking and analysis module executed by a processor, to provide a set of patient medical records satisfying the one or more parameters. A nodal address, indicating one or more variables, is applied to the sorted set of patient medical records to determine a clinically relevant set of patient medical records as the sorted set of patient medical records satisfying the one or more variables. The clinically relevant set of patient medical records is analyzed. A communication is transmitted based on the analyzing to a user to effect treatment, to monitor performance, or to reduce at least one of treatment variability, waste or inefficiency while delivering on intended outcome.

What is claimed is: 
     
         1 . A method for clinical outcome tracking and analysis, comprising:
 receiving one or more parameters;   sorting a plurality of patient medical records to provide a sorted set of patient medical records satisfying the one or more parameters;   applying a nodal address, indicating one or more variables, to the sorted set of patient medical records to determine a clinically relevant set of patient medical records as the sorted set of patient medical records satisfying the one or more variables;   analyzing the clinically relevant set of patient medical records; and
 transmitting a communication based on the analyzing, wherein the transmitting is to a user to effect treatment, to monitor performance, or to reduce at least one of treatment variability, waste or inefficiency while delivering on intended clinical outcome. 
   
     
     
         2 . The method as recited in  claim 1 , wherein the clinical outcome tracking and analysis comprises sorting, outcome tracking, quality of life metrics, toxicity to therapy and cost of care. 
     
     
         3 . The method as recited in  claim 2 , wherein the parameters for sorting comprise sex, age, ethnicity, comorbidities, tobacco use, source of insurance, medical record number, primary care physician, referring physician, hospital, approved service vendors, disease-specific clinical molecular phenotype, therapy intent, stage of therapy, biomarkers, and cost of care. 
     
     
         4 . The method as recited in  claim 1 , wherein the nodal address is represented as a plurality of strings of digits, each of the plurality of strings of digits representing one of the one or more variables. 
     
     
         5 . The method as recited in  claim 4 , wherein the one or more variables include the disease-specific clinical molecular phenotype and a string of digits representing the phenotype is determined based on a directed graph. 
     
     
         6 . The method as recited in  claim 1 , wherein the nodal address is associated with one or more bundles of predetermined patient care services for treatment of the disease. 
     
     
         7 . The method as recited in  claim 1 , wherein analyzing comprises:
 tracking clinical outcomes of one or more patients associated with a disease; and   updating records of the one or more patients with the clinical outcomes of the one or more patients.   
     
     
         8 . The method as recited in  claim 7 , wherein the clinical outcomes comprise at least one of survival, response metrics, quality of life metrics, incidence of drug toxicity, severity of drug toxicity, delivered dose intensity, drugs received, drug interval, drug duration, cost of care, and death. 
     
     
         9 . The method as recited in  claim 1 , wherein analyzing comprises:
 comparing tracked clinical outcomes between patients in the set of patient medical records.   
     
     
         10 . The method as recited in  claim 1 , wherein analyzing comprises:
 identifying a specific patient as a candidate for a specific drug.   
     
     
         11 . The method as recited in  claim 1 , wherein analyzing comprises:
 comparing clinical outcomes between patients based on treatment, cost, or a combination thereof in the set of patient medical records.   
     
     
         12 . The method as recited in  claim 1 , wherein analyzing comprises:
 comparing a therapy to a quality of life.   
     
     
         13 . The method as recited in  claim 1 , wherein transmitting a communication comprises:
 sending at least a portion of the analyzed set of patient medical records to a client device for display.   
     
     
         14 . The method as recited in  claim 1 , wherein transmitting a communication comprises:
 transmitting, in response to a trigger, an alert to a client device, the trigger comprising at least one of diagnosis, progression, dose change, drug change, toxicity, trending towards variance from a desired outcome, and a specific time.   
     
     
         15 . The method as recited in  claim 1 , wherein analyzing comprises:
 comparing outcome performance of a medical professional treating a disease to outcome performance of an aggregate of medical professionals treating the disease.   
     
     
         16 . The method as recited in  claim 1 , wherein the method minimizes biological variability of clinical outcome. 
     
     
         17 . An apparatus for clinical outcome tracking and analysis comprising:
 a processor; and   a memory to store computer program instructions, the computer program instructions when executed on the processor cause the processor to perform operations comprising:
 receiving one or more parameters; 
 sorting a plurality of patient medical records to provide a set of patient medical records satisfying the one or more parameters; 
 applying a nodal address, indicating one or more variables, to the sorted set of patient medical records to determine a clinically relevant set of patient medical records as the sorted set of patient medical records satisfying the one or more variables; 
 analyzing the clinically relevant set of patient medical records; and 
 transmitting a communication based on the analyzing,
 wherein the transmitting is to a user to effect treatment, to monitor performance, or to reduce at least one of treatment variability, waste or inefficiency while delivering on intended outcome. 
 
   
     
     
         18 . The apparatus as recited in  claim 17 , wherein the clinical outcome tracking and analysis comprises sorting, outcome tracking, quality of life metrics, toxicity to therapy and cost of care. 
     
     
         19 . The apparatus as recited in  claim 17 , wherein the parameters for sorting comprise sex, age, ethnicity, comorbidities, tobacco use, source of insurance, medical record number, primary care physician, referring physician, hospital, approved service vendors, disease-specific clinical molecular phenotype, therapy intent, stage of therapy, biomarkers and cost of care. 
     
     
         20 . The apparatus as recited in  claim 17 , wherein the nodal address is represented as a plurality of strings of digits, each of the plurality of strings of digits representing one of the one or more variables. 
     
     
         21 . The apparatus as recited in  claim 20 , wherein the one or more variables include the disease-specific clinical molecular phenotype and a string of digits representing the phenotype is determined based on a directed graph. 
     
     
         22 . The apparatus as recited in  claim 17 , wherein the nodal address is associated with one or more bundles of predetermined patient care services for treatment of the disease. 
     
     
         23 . A computer readable medium storing computer program instructions for clinical outcome tracking and analysis which, when executed on a processor, cause the processor to perform operations comprising:
 receiving one or more parameters;   sorting a plurality of patient medical records to provide a set of patient medical records satisfying the one or more parameters;   applying a nodal address, indicating one or more variables, to the sorted set of patient medical records to determine a clinically relevant set of patient medical records as the sorted set of patient medical records satisfying the one or more variables;   analyzing the clinically relevant set of patient medical records; and   transmitting a communication based on the analyzing,
 wherein the transmitting is to a user to effect treatment, to monitor performance, or to reduce at least one of treatment variability, waste or inefficiency while delivering on intended outcome. 
   
     
     
         24 . The computer readable medium as recited in  claim 23 , wherein the clinical outcome tracking and analysis comprises sorting, outcome tracking, quality of life metrics, toxicity to therapy and cost of care. 
     
     
         25 . The computer readable medium as recited in  claim 23 , wherein the parameters comprise sex, age, ethnicity, comorbidities, tobacco use, source of insurance, medical record number, primary care physician, referring physician, hospital, approved service vendors, disease-specific clinical molecular phenotype, therapy intent, stage of therapy, biomarkers and cost of care. 
     
     
         26 . The computer readable medium as recited in  claim 23 , wherein analyzing comprises:
 tracking clinical outcomes of one or more patients associated with a disease; and   updating records of the one or more patients with the clinical outcomes.   
     
     
         27 . The computer readable medium as recited in  claim 23 , wherein the clinical outcomes comprise at least one of survival, response metrics, quality of life metrics, incidence of drug toxicity, severity of drug toxicity, delivered dose intensity, drugs received, drug interval, drug duration, cost of care, and death. 
     
     
         28 . The computer readable medium as recited in  claim 23 , wherein analyzing comprises:
 comparing clinical outcomes between patients based on treatment, cost, or a combination thereof in the set of patient medical records.   
     
     
         29 . The computer readable medium as recited in  claim 23 , wherein analyzing comprises:
 comparing tracked clinical outcomes between patients in the set of patient medical records.   
     
     
         30 . The computer readable medium as recited in  claim 23 , wherein analyzing comprises:
 identifying a specific patient as a candidate for a specific drug.   
     
     
         31 . The computer readable medium as recited in  claim 23 , wherein analyzing comprises:
 comparing clinical outcome between patients based on treatment, cost, or a combination thereof in the set of patient medical records.   
     
     
         32 . The computer readable medium as recited in  claim 23 , wherein analyzing comprises:
 comparing a therapy to a quality of life.   
     
     
         33 . The computer readable medium as recited in  claim 23 , wherein transmitting a communication comprises:
 sending at least a portion of the analyzed set of patient medical records to a client device for display.   
     
     
         34 . The computer readable medium as recited in  claim 23 , wherein transmitting a communication comprises:
 transmitting, in response to a trigger, an alert to a client device, the trigger comprising at least one of diagnosis, progression, dose change, drug change, toxicity, trending towards variance from a desired outcome, and a specific time.